Information Library

Results for: Internal Medicine - Phase II/III

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Intarcia and Quintiles Finalize Innovative Alliance

    Press Release — December 13, 2011 – To speed development of a potential ground-breaking therapy for Type 2 diabetes – Intarcia Therapeutics, Inc., and Quintiles announced the signing of definitive agreements making Quintiles a financial and strategic partner for the global clinical development of Intarcia’s ITCA 650 (DUROS® continuous subcutaneous delivery of exenatide).

  • Clinical – Smarter Trials, Accelerated Outcomes

    Brochure — February 16, 2011
    Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues.

  • Exclusive Report From Scientific American

    Hear from the Experts — November 9, 2010
    In-depth insights on every angle of the changing health landscape - brought to you by Quintiles Get the report today.

  • Managing Trauma

    Case Study — September 14, 2010
    Quintiles overcame the unpredictability of patient recruitment due to the emergency setup and the client was able to file for approval based on phase II data only.

  • FDA Requirements for Clinical Studies in Pediatric Patients

    White Paper — April 1, 2010
    FDA Requirements for Clinical Studies in Pediatric Patients FDA rules around pediatric drug trials have been tightening, to ensure more targeted data on drug efficacy

  • Regulations for Clinical Studies in Pediatric Patients in the European Union

    White Paper — March 10, 2010
    After the United States issued pediatric drug study requirements, the European Union (EU) passed a regulation that created major changes to clinical studies for pediatric

  • Global Efficiency

    Case Study — February 10, 2010
    Read how Quintiles handled an eight-week hiatus due to a major protocol change and still trimmed two months off the enrollment period.

  • Swift Specialized Recruitment

    Case Study — February 10, 2010
    Experience in the gastroenterology therapeutic area and the implementation of a multimedia recruitment campaign enabled Quintiles to complete enrollment five months ahead of schedule.

Page 1 of 1 (8 results)

Subscribe to Email Based on Your Interests

Set preferences